Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) vs Tiptree Inc. (TIPT)

A side-by-side comparison of Drugs Made In America Acquisition II Corp. Ordinary Shares and Tiptree Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DMII vs TIPT

growth of $100 · dividends reinvested · last 1y
DMII +3.1% (+3.1%/yr)TIPT -5.6% (-5.6%/yr)DMII compounded faster over this window
859095100Start $1002026$103$94
DMII TIPT

DMII vs TIPT: by the numbers

  • •DMII is the larger company ($649M vs $639M market cap).
  • •TIPT trades at the lower trailing earnings multiple (1.63 vs 34.76 P/E), one valuation lens rather than an overall verdict.
  • •TIPT is profitable (7157.17% net margin) while DMII runs a net loss (0.00%).
  • •TIPT pays a dividend (1.38% yield), while DMII has no payments in the available dividend history.

Metrics side by side

Valuation

MetricDMIITIPT
P/E ratio34.761.63
P/B ratio1.310.70

Profitability

MetricDMIITIPT
Gross margin0.00%N/A
Operating margin0.00%-9574.59%
Net margin0.00%7157.17%
ROE2.62%45.62%
ROIC-0.28%N/A

Tiptree Inc.: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.

Dividends

MetricDMIITIPT
Dividend yieldN/A1.38%
Payout ratioN/A2.28%

Growth (annualized)

MetricDMIITIPT
Total return CAGR (5Y)N/A12.25%

Frequently asked

Which has the lower trailing P/E, DMII or TIPT?
TIPT has the lower trailing P/E: DMII trades at 34.76 and TIPT at 1.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does DMII or TIPT pay a bigger dividend?
TIPT pays a dividend (1.38% yield), while DMII has no payments in the available dividend history.
Is DMII or TIPT more profitable?
TIPT runs the higher net margin — DMII at 0.00% versus TIPT at 7157.17%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.